Pyrazinamide resistance and pncA gene mutations in Mycobacterium tuberculosis

被引：118

作者：

Jureen, Pontus ^{[1
,2
]}

Werngren, Jim ^{[1
]}

Toro, Juan-Carlos ^{[1
]}

Hoffner, Sven ^{[1
]}

机构：

[1] Swedish Inst Infect Dis Control, Dept Bacteriol, Solna, Sweden

[2] Karolinska Inst, Tumour & Cell Biol Ctr, Dept Microbiol, Stockholm, Sweden

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2008年 / 52卷 / 05期

关键词：

D O I：

10.1128/AAC.00110-08

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Thirty-four pyrazinamide-resistant and 37 pyrazinamide-susceptible Mycobacterium tuberculosis complex strains were analyzed for pncA gene mutations. None of the sensitive strains had any mutations, apart from silent mutations, whereas all but one resistant strain showed pncA mutations. By using sequencing as a means of early resistance detection, the inconsistency of phenotypic pyrazinamide assays can be circumvented.

引用

页码：1852 / 1854

页数：3

共 50 条

[41] Resistance to pyrazinamide in Russian Mycobacterium tuberculosis isolates: pncA sequencing versus Bactec MGIT 960
Maslov, Dmitry A.
Zaichikova, Marina V.
Chernousova, Larisa N.
Shur, Kirill V.
Bekker, Olga B.
Smirnova, Tatiana G.
Larionova, Elena E.
Andreevskaya, Sofya N.
Zhang, Ying
Danilenko, Valery N.
TUBERCULOSIS, 2015, 95 (05) : 608 - 612
[42] Pyrazinamide resistance of novel mutations in pncA and their dynamic behavior
Ali, Arif
Khan, Muhammad Tahir
Khan, Abbas
Ali, Sajid
Chinnasamy, Sathishkumar
Akhtar, Khalid
Shafiq, Athar
Wei, Dong-Qing
RSC ADVANCES, 2020, 10 (58) : 35565 - 35573
[43] Structure guided prediction of Pyrazinamide resistance mutations in pncA
Malancha Karmakar
Carlos H. M. Rodrigues
Kristy Horan
Justin T. Denholm
David B. Ascher
Scientific Reports, 10
[44] pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis clinical isolates from the southeast region of Brazil
Barco, P.
Cardoso, R. F.
Hirata, R. D. C.
Leite, C. Q. F.
Pandolfi, J. R.
Sato, D. N.
Shikama, M. L.
de Melo, F. Fiuza
Mamizuka, E. M.
Campanerut, P. A. Z.
Hirata, M. H.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (05) : 930 - 935
[45] Non-pncA Gene-Mutated but Pyrazinamide-Resistant Mycobacterium tuberculosis: Why Is That?
Werngren, Jim
Alm, Erik
Mansjo, Mikael
JOURNAL OF CLINICAL MICROBIOLOGY, 2017, 55 (06) : 1920 - 1927
[46] A computational perspective on the dynamic behaviour of recurrent drug resistance mutations in the pncA gene from Mycobacterium tuberculosis
Khan, Taimoor
Khan, Abbas
Ali, Syed Shujait
Ali, Shahid
Wei, Dong-Qing
RSC ADVANCES, 2021, 11 (04) : 2476 - 2486
[47] Relationship between pyrazinamide resistance, loss of pyrazinamidase activity, and mutations in the pncA locus in multidrug-resistant clinical isolates of Mycobacterium tuberculosis
Mestdagh, M
Fonteyne, PA
Realini, L
Rossau, R
Jannes, G
Mijs, W
De Smet, KAL
Portaels, F
Van den Eeckhout, E
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (09) : 2317 - 2319
[48] pncA gene mutations in reporting pyrazinamide resistance among the MDR-TB suspects
Wu, Xiaoyuan
Lu, Wei
Shao, Yan
Song, Honghuan
Li, Guoli
Li, Yan
Zhu, Limei
Chen, Cheng
INFECTION GENETICS AND EVOLUTION, 2019, 72 : 147 - 150
[49] Sequencing of the pncA gene in members of the Mycobacterium tuberculosis complex has important diagnostic applications:: Identification of a species-specific pncA mutation in "Mycobacterium canettii" and the reliable and rapid predictor of pyrazinamide resistance
Somoskovi, Akos
Dormandy, Jillian
Parsons, Linda M.
Kaswa, Michel
Goh, Khye Seng
Rastogi, Nalin
Salfinger, Max
JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (02) : 595 - 599
[50] Drug resistance mechanism of PncA in Mycobacterium tuberculosis
Rajendran, Vidya
Sethumadhavan, Rao
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2014, 32 (02): : 209 - 221

← 1 2 3 4 5 →